Sign in to view content

Two years visual acuity and anatomical outcomes of patients with diabetic macular oedema treated with intravitreal aflibercept in a real life setting

Marko Lukic, MD PhD FEBO FASRS

Video
Published 2019

Related

Patients Ultra-Responsive to Ranibizumab (RBZ): Rates of >4-Step Improvement in Diabetic Retinopathy Severity in DRCR.net Protocol S
Allen Chiang, MD, FASRS
Updates from the Field
2019
Episode 110: June 2018 Issue of Retinal Physician with Dr. Will Parke
Jayanth Sridhar, MD
Member Podcasts
2018
Use of Anti – VEGF Therapy for ROP: When and How
Updates from the Field
2017

Category: Diabetic Retinopathy

See more